低分化甲状腺癌嗜酸细胞变异型的特异性免疫相关基因表达谱
该回顾性研究采用NanoString免疫谱panel分析48例低分化甲状腺癌(PDTC)和24例高分化滤泡性癌(WDFC)的免疫相关基因表达。嗜酸细胞型PDTC相较经典型PDTC高表达LAIR2、CD274等8个基因、低表达NOD1,该特征与瘤内淋巴细胞浸润增加、PD-L1表达及不良预后相关。部分基因特征亦见于Hürthle细胞癌。
要点
- 嗜酸细胞型PDTC具有独特免疫相关基因表达谱,与经典型PDTC不同。
- 该免疫特征伴随瘤内淋巴细胞浸润增加、PD-L1表达及更差预后。
- CD274、DEFB1、IRAK1及PD-L1表达也是HCC相较FTC的标志。
核心结论
- 嗜酸细胞型PDTC具有特异性免疫相关基因表达谱,并证实该亚型预后更具侵袭性。
- 该发现可能为探索嗜酸细胞型PDTC患者的免疫治疗选择提供指导。
研究设计与样本
- 回顾性分析48例PDTC和24例WDFC(包括经典型FTC和HCC)。
- 采用NanoString nCounter PanCancer Immune Profiling panel检测基因表达,并以qRT-PCR验证。
主要发现
- 嗜酸细胞型PDTC相较经典型PDTC高表达LAIR2、CD274、DEFB1、IRAK1、CAMP、LCN2、LY96和APOE,低表达NOD1。
- 该分子特征与瘤内淋巴细胞浸润增加、PD-L1表达及不良预后相关。
- CD274、DEFB1、IRAK1及PD-L1表达也是HCC相较FTC的标志。
- PDTC相较WDFC的差异基因panel与嗜酸细胞表型无关。
临床怎么用
- 对嗜酸细胞型PDTC可关注免疫相关基因表达谱及PD-L1表达,以识别预后更差的患者。
- 该免疫特征为探索免疫治疗选项提供分子层面参考。
局限性
- 为回顾性研究,样本量有限(48例PDTC和24例WDFC)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Poorly differentiated thyroid cancer (PDTC) is a rare, follicular cell-derived neoplasm with an unfavorable prognosis. The oncocytic variant of PDTC may be associated with even more adverse outcome than classical PDTC cases, but its specific molecular features are largely unknown. Our aim was to explore the immune-related gene expression profile of oncocytic and classical PDTC, in correlation with clinical and pathological characteristics (including programmed death ligand 1 [PD-L1] expression) and outcome, and in comparison with a control group of well-differentiated follicular carcinomas (WDFCs), including conventional follicular carcinomas (FTCs) and Hürthle cell carcinomas (HCCs). METHODS: A retrospective series of 48 PDTCs and 24 WDFCs was analyzed by means of NanoString technology employing the nCounter PanCancer Immune Profiling panel. Gene expression data were validated using quantitative real-time polymerase chain reaction. RESULTS: Oncocytic PDTCs showed a specific immune-related gene expression profile, with higher expression of LAIR2, CD274, DEFB1, IRAK1, CAMP, LCN2, LY96, and APOE, and lower expression of NOD1, as compared to conventional PDTCs. This molecular signature was associated with increased intratumoral lymphocytic infiltration, PD-L1 expression, and adverse outcome. Three of these genes, CD274, DEFB1, and IRAK1, as well as PD-L1 expression, were also the hallmarks of HCCs as compared to FTCs. By contrast, the panel of genes differentially regulated in PDTCs as compared to WDFCs was unrelated to the oncocytic phenotype. CONCLUSIONS: Our results revealed a distinctive immune-related gene expression profile of oncocytic PDTC and confirmed a more aggressive outcome in this cancer subtype. These findings may provide guidance when exploring novel immunotherapeutic options for oncocytic PDTC patients.
引用
- Metovic J, Vignale C, Annaratone L, et al. The Oncocytic Variant of Poorly Differentiated Thyroid Carcinoma Shows a Specific Immune-Related Gene Expression Profile. J Clin Endocrinol Metab. 2020. PMID: 32936917. doi:10.1210/clinem/dgaa655
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。